AoE2Insights
  • Analyze game
  • Lobby Browser
  • Teams
  • Login
  • Head to Head

    0
    Wins
    1

    Matches across all leaderboards

  • Unranked
  • RM 1v1
  • RM Team
  • EW 1v1
  • +77 1,499
    Rating
    1,422 -77
    -67 1,827
    Highest Rating
    1,894 +67
    60.9 %
    Win Probability
    39.1 %
    83% Mongols
    Best Civ (WR)
    Bulgarians 80%
    17× Japanese
    Favorite Civ
    Mongols 20×
    83% Nomad
    Best Map (WR)
    Unknown 67%

    LE | Emaxcito2 will win in roughly 11 out of 18 matches against OutPostMalone.

    Rating Development

    -191 1,791 #1529
    Rating
    #706 1,982 +191
    -187 1,988
    Highest Rating
    2,175 +187
    25.0 %
    Win Probability
    75.0 %
    +1,250 2,391
    Matches
    1,141 -1,250
    51.3%
    Win Rate
    52.8%
    +3
    Streak
    -1
    73% Magyars
    Best Civ (WR)
    Hindustanis 89%
    363× Dravidians
    Favorite Civ
    Mongols 68×
    80% Bogland
    Best Map (WR)
    Mediterranean 86%

    OutPostMalone will win in roughly 3 out of 4 matches against LE | Emaxcito2.

    Rating Development

    -83 1,562 #2157
    Rating
    #1179 1,645 +83
    -87 1,565
    Highest Rating
    1,652 +87
    38.3 %
    Win Probability
    61.7 %
    -3,009 337
    Matches
    3,346 +3,009
    55.8%
    Win Rate
    51.1%
    +1
    Streak
    +1
    100% Koreans
    Best Civ (WR)
    Malians 67%
    29× Britons
    Favorite Civ
    Poles 153×
    82% MegaRandom
    Best Map (WR)
    Mountain Pass 80%

    OutPostMalone will win in roughly 8 out of 13 matches against LE | Emaxcito2.

    Rating Development

    -67 1,291
    Rating
    #262 1,358 +67
    -86 1,310
    Highest Rating
    1,396 +86
    40.5 %
    Win Probability
    59.5 %
    -128 16
    Matches
    144 +128
    75.0%
    Win Rate
    56.3%
    -1
    Streak
    +1
    80% Lithuanians
    Best Civ (WR)
    Bulgarians 83%
    Lithuanians
    Favorite Civ
    Magyars 21×
    71% Aftermath
    Best Map (WR)
    Morass 85%

    OutPostMalone will win in roughly 3 out of 5 matches against LE | Emaxcito2.

    Rating Development